HSD17B6


Summary: The protein encoded by this gene has both oxidoreductase and epimerase activities and is involved in androgen catabolism. The oxidoreductase activity can convert 3 alpha-adiol to dihydrotestosterone, while the epimerase activity can convert androsterone to epi-androsterone. Both reactions use NAD+ as the preferred cofactor. This gene is a member of the retinol dehydrogenase family. [provided by RefSeq, Aug 2013].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

GO terms in HSD17B6


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF TAS GO:0003824 catalytic activity
MF IEA GO:0004303 estradiol 17-beta-dehydrogenase activity
MF IEA GO:0004745 retinol dehydrogenase activity
MF TAS GO:0009055 electron transfer activity
MF NAS GO:0016491 oxidoreductase activity
MF IEA GO:0047035 testosterone dehydrogenase (NAD+) activity
Showing 1 to 6 of 12 rows rows per page

Gene expression in normal tissue: HSD17B6

Gene-model tissue-cancer distribution: Bubble Plot

undefinetissue: undefine cancer: undefined model num: 0undefinedtissue: undefined cancer: PANCAN model num: 2

Gene-drug pathway distribution

ERK MAPK signaling1

Pathways in HSD17B6


Loading, please wait...
Database
Pathway ID
Pathway Des.
reactome R-HSA-162582 Signal Transduction
reactome R-HSA-2187338 Visual phototransduction
reactome R-HSA-2453902 The canonical retinoid cycle in rods (twilight vision)
reactome R-HSA-372790 Signaling by GPCR
reactome R-HSA-388396 GPCR downstream signalling
reactome R-HSA-418594 G alpha (i) signalling events
Showing 1 to 6 of 8 rows

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD353 PD0325901 2
Showing 1 to 1 of 1 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in HSD17B6

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​